Clinical Trial Update: Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating sequential AG and modified Folfirinox in metastatic pancreatic adenocarcinoma; phase 1/2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• AG
• Modified FOLFIRINOX (modified FOLFIRINOX)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Pancreatic Adenocarcinoma Metastatic, Chemotherapy Effect | Phase 1, Phase 2 | Status: UNKNOWN